Home > Liver Health > Congress Materials > DDW 2023 Materials
Digestive Disease Week
(DDW 2023)
MAY 6-9, 2023 - CHICAGO, IL
DDW Encore: Non-invasive fibrosis scores as predictors for clinical events in obesity: a longitudinal study
This presentation outlines a longitudinal cohort study which investigated the prognostic potential of six non-invasive scores for NASH-related clinical outcomes in patients with obesity.
Understanding NASH as a metabolic disease
Read more on NASH as a metabolic disease, guideline recommendations, and Novo Nordisk's commitment to liver health
2021 AGA Clinical Care Pathway
Review the 2021 AGA Clinical Care Pathway for risk stratification-based disease management strategies.
Search the Exchange
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.
Additional Information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
